Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 6/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | TYR | P14679 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.34 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.34 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28300226 | 0.98 | LIPG (0.38) | TDP1LIPGALOX5PTGS2KCNH2 | |
| SCHEMBL27671187 | 0.98 | LIPG (0.38) | TDP1LIPGALOX5PTGS2KCNH2 | |
| SCHEMBL28300224 | 0.98 | LIPG (0.38) | TDP1LIPGALOX5PTGS2KCNH2 | |
| Bromide SCHEMBL28162693 | 0.96 | LIPG (0.37) | TDP1LIPGALOX5PTGS2KCNH2 | |
| Bromide SCHEMBL28162683 | 0.96 | LIPG (0.37) | TDP1LIPGALOX5PTGS2KCNH2 | |
| Bromide SCHEMBL28162087 | 0.96 | LIPG (0.37) | TDP1LIPGALOX5PTGS2KCNH2 | |
| SCHEMBL7016897 | 0.94 | HRH3 (0.38) | TYRHCAR3HCAR2TLR8 | |
| Pyrrole SCHEMBL28216728 | 0.91 | ALOX5 (0.34) | TDP1L3MBTL1LIPGALOX5PTGS2 | |
| SCHEMBL6264510 | 0.87 | HCAR2 (0.35) | TDP1L3MBTL1LIPGALOX5PTGS2 | |
| Resorcinol SCHEMBL458917 | 0.84 | ALOX5 (0.45) | TDP1ALOX5PTGS2TYRMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 463 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113347969-A | Composition for eliminating senescent cells | 维也纳自然资源与生命科学大学 | 2021-09-03 | — | — | CN | claimed |
| CN-111065391-A | Compositions containing conjugates of cannabinoid analogs and methods of use | 维利法姆企业有限责任公司 | 2020-04-24 | — | — | CN | claimed |
| EP-1680116-A1 | COMBINATION TREATMENT OF OBESITY INVOLVING SELECTIVE CB1-ANTAGONISTS AND LIPASE INHIBITORS | Solvay Pharmaceuticals GmbH (DE) | 2006-07-19 | — | — | EP | claimed |
| EP-1200094-B1 | OPHTHALMIC COMPOSITIONS CONTAINING ANTIBIOTICS AND NSAIDS | ALLERGAN INC (US) | 2006-06-21 | — | — | EP | claimed |
| EP-1663215-A1 | NOVEL MEDICAL USE OF SELECTIVE CB1- RECEPTOR ANTAGONISTS | Solvay Pharmaceuticals GmbH (DE) | 2006-06-07 | — | — | EP | claimed |
| US-20050101585-A1 | Use of selective CB1-antagonists in medical treatments | SOLVAY PHARMACEUTICALS GMBH (DE) | 2005-05-12 | — | — | US | claimed |
| WO-2005039579-A1 | COMBINATION TREATMENT OF OBESITY INVOLVING SELECTIVE CB1-ANTAGONISTS AND LIPASE INHIBITORS | SOLVAY PHARMACEUTICALS GMBH (DE) | 2005-05-06 | — | — | WO | claimed |
| WO-2005020992-A1 | NOVEL MEDICAL USE OF SELECTIVE CB1-RECEPTOR ANTAGONISTS | SOLVAY PHARMACEUTICALS GMBH (DE) | 2005-03-10 | — | — | WO | claimed |
| WO-2024125320-A1 | USE OF DIPYRIDAMOLE AND PREPARATION THEREOF IN PREVENTING AND TREATING ATOPIC DERMATITIS | 智泽童康(广州)生物科技有限公司 | 2024-06-20 | — | — | WO | disclosed |
| WO-2024110503-A1 | METHODS FOR TREATING EYETEAR FILM DEFICIENCY | BAUSCH + LOMB IRELAND LIMITED (IE) | 2024-05-30 | — | — | WO | disclosed |
| WO-2024110505-A1 | METHODS FOR TREATING EYETEAR FILM DEFICIENCY | BAUSCH + LOMB IRELAND LIMITED (IE) | 2024-05-30 | — | — | WO | disclosed |
| US-20240165147-A1 | Methods for Treating Eyetear Film Deficiency | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT | 2024-05-23 | — | — | US | disclosed |
| US-20240165019-A1 | Methods for Treating Eyetear Film Deficiency | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT | 2024-05-23 | — | — | US | disclosed |
| US-20240102034-A1 | CANNABIS PLANT WITH INCREASED CANNABIGEROLIC ACID | CANOPY GROWTH CORPORATION (CA) | 2024-03-28 | — | — | US | disclosed |
| US-5840913-A | CATALYTIC N-ALKYLATION OF A PYRAZOLE BY REACTING WITH AN ALCOHOL; LIQUID PHASE; NON-HETEROGENOUS ACID CATALYSTS | BASF AKTIENGESELLSCHAFT (DE) | 1998-11-24 | — | — | US | disclosed |
| US-5744614-A | Preparation of 3,5-diarylpyrazoles | BASF AKTIENGESELLSCHAFT (DE) | 1998-04-28 | — | — | US | disclosed |
| EP-0813526-A1 | PROCESS FOR PREPARING N-SUBSTITUTED PYRAZOLES | BASF AKTIENGESELLSCHAFT (DE) | 1997-12-29 | — | — | EP | disclosed |
| EP-0802906-A1 | PROCESS FOR PRODUCING 3,5-DIARYL PYRAZOLENE | BASF AKTIENGESELLSCHAFT (DE) | 1997-10-29 | — | — | EP | disclosed |
| WO-1996027589-A1 | PROCESS FOR PREPARING N-SUBSTITUTED PYRAZOLES | BASF AKTIENGESELLSCHAFT (DE) | 1996-09-12 | — | — | WO | disclosed |
| WO-1996021650-A1 | PROCESS FOR PRODUCING 3,5-DIARYL PYRAZOLENE | BASF AKTIENGESELLSCHAFT (DE) | 1996-07-18 | — | — | WO | disclosed |